Gene · 4300
Papers2,395
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,395
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The histone acylation reader ENL/AF9 regulates aging in Drosophila melanogaster. | Neurobiol Aging | 2024 | 39405796 | PubTator, text mining | PubMed |
Psychotic symptoms associated increased CpG methylation of metabotropic glutamate receptor 8 gene in Chinese Han males with schizophrenia and methamphetamine induced psychotic disorder: a longitudinal study. | Schizophrenia (Heidelb) | 2024 | 39384625 | PubTator, text mining | PubMed |
| Efficient generation of human NOTCH ligand-expressing haemogenic endothelial cells as infrastructure for in vitro haematopoiesis and lymphopoiesis. | Nat Commun | 2024 | 39227582 | PubTator, text mining | PubMed |
| The Role of Epithelial-to-Mesenchymal Transition Transcription Factors (EMT-TFs) in Acute Myeloid Leukemia Progression. | Biomedicines | 2024 | 39200378 | PubTator, text mining | PubMed |
| MLL-AF9 regulates transcriptional initiation in mixed lineage leukemic cells. | J Biol Chem | 2024 | 39002676 | PubTator, text mining | PubMed |
| Epigenetic modulators provide a path to understanding disease and therapeutic opportunity. | Genes Dev | 2024 | 38914477 | PubTator, text mining | PubMed |
| Genetically Encoded Epitope Tag for Probing Lysine Acylation-Mediated Protein-Protein Interactions. | ACS Chem Biol | 2024 | 38829775 | PubTator, text mining | PubMed |
| Post-translational modification-dependent oligomerization switch in regulation of global transcription and DNA damage repair during genotoxic stress. | Nat Commun | 2024 | 38750015 | PubTator, text mining | PubMed |
| Structural studies of intrinsically disordered MLL-fusion protein AF9 in complex with peptidomimetic inhibitors. | Protein Sci | 2024 | 38747396 | PubTator, text mining | PubMed |
| Protein crotonylation: Basic research and clinical diseases. | Biochem Biophys Rep | 2024 | 38586826 | PubTator, text mining | PubMed |
| The mechanisms, regulations, and functions of histone lysine crotonylation. | Cell Death Discov | 2024 | 38331935 | PubTator, text mining | PubMed |
| Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia Harboring KMT2A Rearrangement and Its Prognostic Factors. | Cell Transplant | 2024 | 38270130 | PubTator, text mining | PubMed |
| Germline USP36 Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non-Small Cell Lung Cancer. | Clin Cancer Res | 2024 | 38261467 | PubTator, text mining | PubMed |
| PHF6 suppresses self-renewal of leukemic stem cells in AML. | bioRxiv | 2024 | 38260439 | PubTator, text mining | PubMed |
| Detection of Genomic Structural Variations Associated with Drug Sensitivity and Resistance in Acute Leukemia. | Cancers (Basel) | 2024 | 38254907 | PubTator, text mining | PubMed |
| Enhancer-activated RET confers protection against oxidative stress to KMT2A-rearranged acute myeloid leukemia. | Cancer Sci | 2024 | 38226414 | PubTator, text mining | PubMed |
| Prognostic significance of multiparametric flow cytometry minimal residual disease at two time points after induction in pediatric acute myeloid leukemia. | BMC Cancer | 2024 | 38195455 | PubTator, text mining | PubMed |
| An aging-related immune landscape in the hematopoietic immune system. | Immun Ageing | 2024 | 38169405 | PubTator, text mining | PubMed |
| Prognosis and risk factors for ASXL1 mutations in patients with newly diagnosed acute myeloid leukemia and myelodysplastic syndrome. | Cancer Med | 2024 | 38146893 | PubTator, text mining | PubMed |
| Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study. | Leukemia | 2024 | 38001170 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4300/papers?page=5